Fig. 8From: Challenges and strategies associated with CAR-T cell therapy in blood malignanciesCombination therapy. Combination therapy using CART cells with chemotherapy drugs, radiotherapy, Bruton’s tyrosine kinase (BTK) inhibitors, PI3K inhibitors, and other agents such as Bcl-2 inhibitors enhance anti-tumor efficacyBack to article page